Sustainability drives pharma's future
- March 2004
In an article published in the Pharmaceutical Executive in March, Lise Kingo, Executive Vice President of Corporate Stakeholder Relations, is interviewed about sustainability.
The article, “Sustainability drives Pharma’s future” points out the growing conviction that the balancing of economic, social, and environmental issues is an indication of a company’s future success, and that investors look at these issues when evaluating companies’ “financial fitness.”
Following this lead-in, the story calls attention to Novo Nordisk’s number-one ranking in the Dow Jones list of most-sustainable companies.
Read a pdf version of the full article.
